Jefferies Group’s The Oncology Institute Warrant TOIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$52.6K Hold
95,200
﹤0.01% 1511
2022
Q2
$47.6K Sell
95,200
-60,257
-39% -$55.4K ﹤0.01% 1406
2022
Q1
$179K Sell
155,457
-19,543
-11% -$17.8K ﹤0.01% 1285
2021
Q4
$121K Buy
175,000
+135,340
+341% +$167K ﹤0.01% 1453
2021
Q3
$50.4K Hold
39,660
﹤0.01% 1604
2021
Q2
$68.6K Hold
39,660
﹤0.01% 1525
2021
Q1
$47.6K Sell
39,660
-10,465
-21% -$19.4K ﹤0.01% 1512
2020
Q4
$97.7K Hold
50,125
﹤0.01% 1460
2020
Q3
$85K Hold
50,125
﹤0.01% 1256
2020
Q2
$74 Buy
+50,125
New +$71.9K ﹤0.01% 1141

Other funds holding TOIIW

Jefferies Group's TOIIW Position: Q3 2022 in Review

Jefferies Group held its The Oncology Institute Warrant (TOIIW) position steady in Q3 2022 at 95,200 shares worth $52.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Jefferies Group first reported a position in TOIIW in Q2 2020 and has held it in 10 quarters since. The position peaked at $179K in Q1 2022. 12 funds tracked by Wall St. Rank hold TOIIW as of Q3 2022.

  • Jefferies Group held 95,200 shares of The Oncology Institute Warrant worth $52.6K as of Q3 2022.
  • Jefferies Group left its The Oncology Institute Warrant share count unchanged in Q3 2022.
  • The Oncology Institute Warrant made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1511 holding.
  • Jefferies Group first reported a position in The Oncology Institute Warrant in Q2 2020 and has held it in 10 quarters since.
  • Jefferies Group's The Oncology Institute Warrant position peaked at $179K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held The Oncology Institute Warrant as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.